Ascribe Bioscience is a series a startup. 1 investor tracked.
Ascribe Bioscience is a company founded in 2017 headquartered in the United States. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Ascribe Bioscience is a company focused on discovering and developing novel bio-inspired solutions for agriculture.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.